Publish date: 8 September 2023
Przeczytasz w 3 min
The largest research project to date conducted by the INVICTA Research and Development Center team has been featured in PLOS Computational Biology. In the proprietary software AIOO® and the world’s only Genetic Prediction of Stimulation (GPS™) study, we harness artificial intelligence (AI) and molecular biology to create new possibilities in the treatment of fertility disorders.
👉 AIOO® software and the Genetic Prediction of Stimulation (GPS™) study are proprietary solutions developed within the INVICTA Group and are exclusively available to patients at INVICTA Clinics.
👉 As the only ones in the world, INVICTA Clinics offer female patients the opportunity to undergo the Genetic Prediction of Stimulation (GPS™) study. This enables INVICTA experts to predict how a patient may respond to the ovarian stimulation process, allowing them to propose a personalized treatment plan that increases the chances of obtaining high-quality eggs. Importantly, a well-matched stimulation protocol enhances patient safety.
👉 AIOO® and GPS™ are solutions that utilize artificial intelligence mechanisms to enhance the effectiveness of in vitro procedures.
👉 The predictions of the model developed by the INVICTA Research and Development Center have been confirmed using real data. The results obtained confirm that the model developed by CBR INVICTA can predict the actual number of eggs a patient can obtain during hormonal stimulation with very high accuracy.
👉 In the research process, using innovative methods based on artificial intelligence, the INVICTA Research and Development Center identified previously unknown combinations of genetic variants correlated with stimulation outcomes. Utilizing this data, the developed model is more accurate in assessing a patient’s ovarian reserve.
👉 AIOO® and GPS™ represent a significant step towards personalized, effective, and safe treatment of fertility disorders.
Publication in the prestigious journal PLOS Computational Biology serves as the best validation of the scientific value of our project. The work of the experts at the INVICTA Research and Development Center has also been described on the most well-known molecular biology-themed website in the world, GenomeWeb, as well as on the EurekAlert portal, affiliated with the American Association for the Advancement of Science.
AIOO® and GPS™ in PLOS Computational Biology: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1011020
